Cresset Asset Management’s Twist Bioscience TWST Stock Holding History

Cresset Asset Management’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-6,093	Closed	-$275K	–	2197
2024 Q3	$275K	Sell	6,093 -2,391	-28%	-$114K	﹤0.01%	1841
2024 Q2	$418K	Sell	8,484 -440	-5%	-$17.9K	﹤0.01%	1530
2024 Q1	$306K	Sell	8,924 -175	-2%	-$6.32K	﹤0.01%	1572
2023 Q4	$335K	Buy	+9,099	New	+$210K	﹤0.01%	1433
2021 Q4	–	Sell	-3,142	Closed	-$336K	–	1297
2021 Q3	$336K	Buy	3,142 +120	+4%	+$13.7K	﹤0.01%	796
2021 Q2	$403K	Buy	3,022 +10	+0.3%	+$1.16K	0.01%	639
2021 Q1	$373K	Buy	+3,012	New	+$457K	0.01%	577

Other funds holding TWST

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cresset Asset Management's TWST Position: Q4 2024 in Review

Cresset Asset Management sold out of Twist Bioscience (TWST) in Q4 2024, closing a stake of 6,093 shares — an estimated $275K sold.

Cresset Asset Management first reported a position in TWST in Q1 2021 and held it in 7 quarters. The position peaked at $418K in Q2 2024. 246 funds tracked by Wall St. Rank hold TWST as of Q4 2024.

Cresset Asset Management reported no remaining Twist Bioscience position as of Q4 2024 after selling out during the quarter.
Cresset Asset Management sold 6,093 Twist Bioscience shares in Q4 2024, an estimated $275K.
Cresset Asset Management first reported a position in Twist Bioscience in Q1 2021 and held it in 7 quarters.
Cresset Asset Management's Twist Bioscience position peaked at $418K in Q2 2024.
246 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2024.

Based on Cresset Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.